Ads
related to: abbvie patient assistanceget.patientassistanceprograms.com has been visited by 10K+ users in the past month
Search results
Here's What This Drug News Could Mean for AbbVie's Shareholders
Motley Fool· 2 years agoOn May 11, AbbVie (NYSE: ABBV) announced positive top-line results in its phase 3 clinical trial of...
AbbVie's Humira gets a U.S. rival, but costs could stay high
Reuters via Yahoo Finance· 1 year agoU.S. patients will finally get access to cheaper versions of AbbVie Inc’s blockbuster arthritis drug...
This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
Motley Fool· 1 year agoAbbVie (NYSE: ABBV) recently shared positive top-line results from its phase 3 clinical trial of...
Cheaper competition for Humira is hitting the market, but savings will depend on your insurance
Associated Press via Yahoo News· 10 months agoPatients who take the autoimmune disease treatment Humira may see some price relief when several...
What Could This Drug News Mean for AbbVie?
Motley Fool· 2 years agoIn late July, AbbVie (NYSE: ABBV) applied for a new indication with the European Medicines Agency (EMA) for Rinvoq to treat adult patients with...
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
Motley Fool· 2 years agoThe European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) recently...
Why Investors Should Care About Novartis' Latest Label Expansion -- It Could Mean Billions
Motley Fool· 10 months agoEarlier this month, Novartis' (NYSE: NVS) smash-hit immunology medicine Cosentyx became the first...
Could This Indication Provide a Lift for Bristol Myers Squibb's Stock?
Motley Fool· 1 year agoLate last month, Bristol Myers Squibb's (NYSE: BMY) immunology drug, Sotyktu, received good news....
Good news for consumers, bad news for AbbVie as its blockbuster drug Humira faces competition
Chicago Tribune via Yahoo News· 1 year agoCHICAGO — One of the most popular prescription medications in the world is about to face fierce competition in the U.S. — something that could mean lower prices for the drug but a difficult ...
Novartis (NVS) to Divest Xiidra, SAF312 to Streamline Focus
Zacks via Yahoo Finance· 10 months agoNovartis NVS, a leading pharmaceutical company, recently made a strategic decision to divest its...
Ads
related to: abbvie patient assistanceget.patientassistanceprograms.com has been visited by 10K+ users in the past month
